Revamped PBS rules for COVID-19 antiviral and MenB vax now in effect

A new hexavalent vaccine for infants has also been added to the NIP.

Patients aged 50-59 with one chronic condition are now eligible for the COVID-19 antiviral nirmatrelvir–ritonavir (Paxlovid) under the PBS.

The PBAC recommended the expanded criteria a week ago to ensure rapidly expiring stocks were used up, but until now, the timeline for the change was unclear.